NSN 6550-01-556-0936
NSN Parts Associated with NSN 6550-01-556-0936 (6550015560936) of Reagent Set Blood G- Submit a Quote
NSN 6550-01-556-0936 is a type of Reagent Set Blood G component is now available in stock at One Click Purchasing. NSN codes are a unique numeric serial number assigned by the Defense Logistics Agency (DLA) for all items acquired, stocked, and circulated within the federal supply chain. With NSNs, identifying items is made much easier, ensuring simplified purchasing processes where customers can guarantee that they only procure exact items as necessary.
At One Click Purchasing, owned and operated by ASAP Semiconductor LLC, we prioritize the supply of high-quality, authenticated NSN parts with NSN 6550-01-556-0936 at competitive prices. With an extensive supply-chain network, we guarantee the fastest turnaround times in the industry and a 95% on-time delivery track record. If you would like to obtain a rapid quote for parts with the NSN 6550-01-556-0936, please complete the instant RFQ form below, and a dedicated representative will contact you shortly.
Information of NSN 6550-01-556-0936 (6550015560936)
| Alternate NSN : 6550-01-556-0936 |
| Manufacturers : becton dickinson and company |
| CAGE Code : 0GKS0 |
| Item Name : Reagent Set Blood G |
| NIIN : 015560936 |
| NCB Code : USA (01) |
Part Number's List for NSN 6550-01-556-0936, 6550015560936
| Part No | Manufacturer | Item Name | RFQ |
|---|---|---|---|
| 331358 | Avl |
Product Details of NSN 6550015560936
| MRC | Criteria | Characteristic |
|---|---|---|
| CXCY | Part Name Assigned By Controlling Agency | BD ONCOMARK CD2 FITC/CD7 PE/CD3 PERCP-CY5.5 |
| FEAT | Special Features | INTENDED FOR IN VITRO FLOW CYTOMETRIC IMMUNOPHENOTYPING OF NORMAL T-CELL DEVELOPMENT AND ABERRANT EXPRESSION OF T-CELL SURFACE MARKERS IN VARIOUS T-CELL NEOPLASIAS; THE ANTIGENS RECOGNIZED BY THESE REAGENTS ARE PRESENT ON NORMAL T CELLS, ONE OR MORE OF THEM IS FREQUENTLY EXPRESSED AT DIFFERENT LEVELS OR ABSENT IN ABNORMAL T CELLS; ONE OR MORE OF THE ANTIGENS DETECTED BY THESE ANTIBODIES MIGHT BE ABERRANTLY EXPRESSED IN MYELOID LEUKEMIA; CD2/CD7/CD3 ASSAYS ARE USED IN THE DIAGNOSIS OF HEMATOLOGIC DISORDERS |
| MRC | Decoded Requirement | Clear Text Reply |